Jackson Square Capital
LLY icon

Jackson Square Capital’s Eli Lilly LLY Stock Holding History

Jackson Square Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.7M Sell
18,782
-90
-0.5% -$106K 3.26% 7
2026
Q2 		$22.6M Buy
18,872
+309
+2% +$316K 3.15% 7
2026
Q1 		$17.1M Buy
18,563
+126
+0.7% +$128K 3.58% 6
2025
Q4 		$19.8M Buy
18,437
+3,875
+27% +$3.71M 3.92% 7
2025
Q3 		$11.1M Sell
14,562
-5,749
-28% -$4.28M 2.42% 9
2025
Q2 		$15.8M Buy
20,311
+1,149
+6% +$893K 3.52% 5
2025
Q1 		$15.8M Sell
19,162
-38
-0.2% -$31.6K 5.15% 3
2024
Q4 		$14.8M Sell
19,200
-3,677
-16% -$3.04M 3.57% 6
2024
Q3 		$20.3M Sell
22,877
-1,318
-5% -$1.18M 5.03% 4
2024
Q2 		$21.9M Buy
24,195
+112
+0.5% +$89.6K 5.39% 4
2024
Q1 		$18.7M Buy
24,083
+35
+0.1% +$24.9K 4.82% 4
2023
Q4 		$14M Sell
24,048
-101
-0.4% -$59K 4.51% 3
2023
Q3 		$13M Buy
24,149
+486
+2% +$250K 5.21% 3
2023
Q2 		$11.1M Sell
23,663
-2,095
-8% -$879K 4.46% 3
2023
Q1 		$8.85M Buy
25,758
+2,049
+9% +$691K 3.96% 4
2022
Q4 		$8.67M Sell
23,709
-675
-3% -$239K 4.08% 2
2022
Q3 		$7.88M Sell
24,384
-645
-3% -$204K 3.85% 4
2022
Q2 		$8.12M Buy
25,029
+548
+2% +$164K 3.43% 4
2022
Q1 		$7.01M Buy
24,481
+1,813
+8% +$467K 2.19% 9
2021
Q4 		$6.26M Buy
22,668
+492
+2% +$125K 1.8% 13
2021
Q3 		$5.12M Sell
22,176
-36
-0.2% -$8.88K 1.67% 18
2021
Q2 		$5.1M Sell
22,212
-276
-1% -$55.4K 1.64% 21
2021
Q1 		$4.2M Buy
22,488
+4,340
+24% +$849K 1.6% 21
2020
Q4 		$3.06M Sell
18,148
-2,524
-12% -$377K 1.18% 32
2020
Q3 		$3.06M Buy
20,672
+932
+5% +$144K 1.35% 28
2020
Q2 		$3.24M Buy
19,740
+8,234
+72% +$1.26M 1.64% 24
2020
Q1 		$1.6M Buy
11,506
+1,586
+16% +$218K 1.24% 31
2019
Q4 		$1.3M Buy
+9,920
New +$1.15M 0.75% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Jackson Square Capital's LLY Position: Q3 2026 in Review

Jackson Square Capital reduced its Eli Lilly (LLY) stake by 0.48% in Q3 2026, selling an estimated $106K and leaving 18,782 shares worth $21.7M. The position accounts for 3.26% of the portfolio, ranked #7.

Jackson Square Capital first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $22.6M in Q2 2026. 987 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Jackson Square Capital held 18,782 shares of Eli Lilly worth $21.7M as of Q3 2026.
  • Jackson Square Capital sold 90 Eli Lilly shares in Q3 2026, an estimated $106K.
  • Eli Lilly made up 3.26% of Jackson Square Capital's portfolio in Q3 2026, its #7 holding.
  • Jackson Square Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • Jackson Square Capital's Eli Lilly position peaked at $22.6M in Q2 2026.
  • 987 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.